+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Respiratory Care Devices Market by Application, Device Types, Product Type, End Users, Countries, and Companies Analysis 2026-2034

  • PDF Icon

    Report

  • 200 Pages
  • February 2026
  • Region: Global
  • Renub Research
  • ID: 5546190
Respiratory Care Devices Market is expected to grow from US$ 27.83 billion in 2025 to US$ 49.93 billion by 2034, at a CAGR of 6.71% from 2026 to 2034. The market is growing due to an increase in the prevalence of respiratory diseases, a rise in the geriatric population, and increasing demand for home-based respiratory care solutions. Advancements in ventilation, oxygen therapy, and monitoring devices make further support for sustained market growth.

Respiratory Care Devices Market Overview

The target market for respiratory care equipment comprises patients, hospitals, and other healthcare settings that require the equipment or products for treating patients with respiratory disorders. The equipment is used for supporting, monitoring, or enhancing the breathing capabilities of patients with acute or chronic respiratory disorders. The equipment assists with functions such as supporting the respiratory system, oxygen supply, control of airflow, as well as airway clearance. The types of respiratory care equipment include respirators, oxygen concentrators, CPAP or BiPAP, nebulizers, inhalers, and respiratory care monitoring systems. The equipment is often used for treating patients with respiratory disorders like asthma, COPD, sleep apnea, pneumonia, or respiratory distress.

Globally, the use of respiratory care devices has shown considerable popularity because of the rising incidence of respiratory diseases, air pollution, smoking, and aging population demographics. The COVID-19 pandemic has underlined the vital need for respiratory support technology, thus accelerating their usage and investments across the world. The trend towards home-care services, advancements in user-friendly respiratory devices, and the development of better access to healthcare services in developing countries have further promoted their usage. The awakening regarding the early diagnosis and long-term management of respiratory diseases is also supporting the demand for these devices.

Key Market Drivers in the Respiratory Care Devices Market

Rising Prevalence of Chronic Respiratory Diseases

Chronic Respiratory Diseases, in 2023, accounted for 569.2 million cases and 4.2 million deaths. The rising number of chronic respiratory diseases is one of the key factors acting as drivers for the respiratory care devices market. This is because diseases such as Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, and Pulmonary Fibrosis are increasingly being witnessed because of the growing average life expectancy, increased prevalence of smoking, occupational exposure, and environmental air pollution. These diseases require prolonged care, which can be provided by respiratory care devices such as Inhalers, Nebulizers, Oxygen Therapy, and Non-Invasive Ventilators. The growing recognition of early detection and control encourages many patients and clinicians to consider respiratory support options. Furthermore, improved survival rates and life expectancy add to the growing pool of Chronic Respiratory Disease patients. Chronic Respiratory Diseases are the sixth leading cause of death in the WHO European Region, killing nearly 400,000 individuals annually. Around 80% of deaths due to Chronic Respiratory Diseases are because of Chronic Obstructive Pulmonary Disease.

Increasing Demand for Home-Based Respiratory Care

The shift toward home-based healthcare is one of the key factors driving the respiratory care devices market. Patients and healthcare systems are increasingly showing preference for home care owing to cost-effectiveness, convenience, and better quality of life. Advances in portable, lightweight, and user-friendly respiratory care devices have enhanced the feasibility of home-based treatment. Devices like home ventilators, oxygen concentrators, CPAP, and BiPAP facilitate the management of chronic respiratory conditions outside hospitals. The trend is further supported by aging populations and an increasing prevalence of long-term respiratory conditions. Home-based care also decreases hospital readmission and overall healthcare burden. May 2025, ABM Respiratory Care an innovator in respiratory therapy solutions announced initiation of a multicenter home care study with Delve Health, a trailblazer in decentralized clinical trial technology, to examine the effect of its BiWaze® Clear System in patients living with bronchiectasis.

Technological Advancements and Innovation

The result of never-ending technology developments in the sector has contributed greatly to the growth of the market for respiratory care devices. Smart ventilators and smart inhalers with advanced bioreceptors are prominent in this technology revolution. Digital solutions for monitoring and using oxygen delivery systems and other devices make a significant impact in this sector. Battery-powered and wearable devices for the respiratory segment increase the ease of movement for the user. Innovations in the industry aim to minimize noise and make the device user-friendly. April 2024, Getinge has announced the latest innovation in this sector with the advent of the Servo-c mechanical ventilator. The device has finally been able to make a landmark contribution to meeting the widespread requirements of patients in the country for both the pediatric and adult segments.

Challenge in the Respiratory Care Devices Market

High Cost of Advanced Respiratory Devices

High cost remains a principal challenge to the marketability of advanced respiratory care devices. Advanced ventilators, monitoring systems, and home respiratory equipment demand huge investment, hence their limited availability in the low- and middle-income group of economies. In addition to it, the overall cost is increased by maintenance, consumables, and replacement parts. Poor reimbursement coverage in some healthcare systems limits adoption. The hospitals and patients would settle for a lower cost, which potentially reduces the ability of advanced technologies. Addressing affordability while maintaining performance and quality remains the greatest challenge for the manufacturers and healthcare providers.

Regulatory Complexity and Skilled Workforce Requirements

Regulatory challenges are brought about by complexities in the respiratory care devices market. Varying manufacturers are under strict regulatory standards that border on safety, performance, and quality, which means an increased developmental time and costs. Furthermore, devices that provide respiratory care often demand use that is appropriate, mostly by highly trained healthcare professionals as well as patients. This aspect creates a shortage of skilled respiratory therapists and technicians in some regions and limits device utilization. Training and support programs become very imperative but add to operational costs. There is a need to pay critical attention to finding a way out of this regulatory pathway and workforce constraint for the market to grow sustainably.

Respiratory Care Monitoring Devices Market

The market for respiratory care monitoring devices concentrates on devices used for the continuous monitoring of patients’ respiratory functions. These devices consist of pulse oximeters, capnography monitors, spirometers, and respiratory rate monitors. They find wide applications in the early diagnosis of the complications associated with breathing in intensive care units and in the management of patients in-home setups. The increasing number of cases associated with respiratory conditions worldwide and the applications in intensive care units for continuous monitoring are the major forces fueling the demand for this technology. Improvements in sensor technology, including the use of wireless connectivity for the monitoring of patients from a distance using wearable devices like portable monitoring devices, will sustain the future growth of this technology.

Respiratory Care Diagnostic Devices Market

The respiratory care diagnostic devices market comprises products used for detecting and analyzing respiratory disorders. Technologies like spirometry, peak flow meters, polysomnographic recorders, and image-based diagnostic equipment are used for detecting conditions such as asthma, COPD, and sleep apnea. Increasing knowledge about the importance of early diagnosis and preventive healthcare is fueling the adoption of diagnostic equipment. Medical institutions are turning towards advanced diagnostic equipment with accuracy and minimally-invasive capabilities for decision-making purposes. Technological developments have led to increased portability, simplified usability, and connectivity capabilities for data sharing. An upswing in the number of outpatient institutions and diagnostic labs is also promoting this market development. With the rising incidence of respiratory diseases, there is a heightened need for sophisticated respiratory diagnostic equipment.

Nebulizers Respiratory Care Devices Market

The nebulizers respiratory care devices market is growing due to the extensive usage of nebulization technology in administering medications directly into the lungs of patients. Nebulizers are largely used in the treatment of patients with asthma, COPD, cystic fibrosis, and other respiratory complications. Nebulizers are very useful in the treatment of children and the elderly population who have difficulty in using inhalers. The development of nebulizer technology in terms of mesh nebulizers and ultrasonic nebulizers has helped improve the efficiency of treatment, decreased the time for nebulization, and made the device handier for patients. The trend of preferring home-based respiratory care is propelling the market for nebulizers forward.

OSA Respiratory Care Devices Market

The main focus for the obstructive sleep apnea (OSA) respiratory care devices industry is the treatment of sleep-disordered breathing. CPAP, BiPAP, and oral appliances are frequently employed to keep the patency of the airway passage during sleep. Growing consciousness regarding sleep apnea and its association with cardiovascular events and metabolic syndrome is propelling the treatment statistics. The growing number of obese individuals and the increasing number of senior citizens are further accelerating the demand. Enhancements in comfort, reduced noise, and monitoring capabilities are further propelling advancements in the development of OSA respiratory care devices. The home care treatment approach continues to gain popularity.

Respiratory Care Devices Hospitals Market

The respiratory care devices used by hospitals make up a significant end-use segment, and this is mainly due to increasing demands for advanced respiratory care devices for patient assistance in hospitals and other healthcare settings. Hospitals require breathing assistance devices such as ventilators and oxygen delivery devices for patient treatment and management. Increased admissions at hospitals for treatment due to respiratory problems and other surgeries also support growth for market penetration and expansion. Moreover, critical care investment and emergency preparedness also create a significant demand for these devices at hospitals and healthcare settings today.

United States Respiratory Care Devices Market

The American respiratory care devices market is one of the largest in the world; its prominent growth being attributed to the widespread prevalence of chronic respiratory disorders such as COPD, asthma, and sleep apnea. The aging population and rising incidence of obesity levels trigger demand for respiratory assistance devices in the country. Strong and developed infrastructure and reimbursements in the United States allow for comprehensive adoption of respiratory devices in healthcare settings such as hospitals, medical institutions, and home care settings. Innovation in devices takes the stage; smart and connected portable devices see mass adoption in the USA. “Today, home care and telemedicine have led the demand for home use of devices such as oxygen concentrators, home CPAPs, and home ventilators.” Oct 2025, “Synchrony Medical, a medical technology company on a mission to reinvent respiratory care, today launched its innovative LibAirty(TM) Airway Clearance System in the USA.” This move marks the beginning of a new era for patients suffering from chronic respiratory disorders; providing innovative home therapy for improving day-to-day breathing and overall quality of life.

Germany Respiratory Care Devices Market

The respiratory care devices market in Germany is fueled by its highly developed medical infrastructure and superior medical practice, and the growing aging population. Chronic diseases and sleep disorders are major contributors in this market. Early diagnostic and management strategies in Germany promote the demand for highly advanced diagnosing and monitoring devices. A convenient and developed reimbursement system in Germany encourages the uptake of respiratory therapy. Modern ventilators, oxygen therapy devices, and CPAP devices in hospitals and home care settings gain traction in Germany. Innovation and quality manufacturing in the field of medical technology in Germany also stimulate the market growth. February 2022 AstraZeneca and Honeywell have formed a business relationship in order to produce and commercially market the latest range of respiratory inhalers, which will have propellants of nearly zero-global-warming potential for treating asthma and patients suffering from chronic obstructive pulmonary disease.

India Respiratory Care Devices Market

The Indian respiratory care devices market is growing at a fast pace due to increasing levels of air pollution, smoking cases, and cases of breathing disorders. Large population and rising awareness regarding breathing health create demand for economical breathing solutions. Government initiatives to improve healthcare and critical care needs encourage market growth. The private healthcare segment is also promoting breathing assistance devices and other breathing care products for treatment and management of breathing disorders. There is a huge demand for nebulizers, oxygen concentrators, and simple monitoring devices. August 2022 - AstraZeneca India has partnered with Alveofit, a SaaS and IoT-enabled breathing healthcare platform, to provide IOT-enabled handheld spirometers to all hospitals in the country. The main purpose of this strategic partnership is to incorporate current technological developments and advancements in the diagnosis and management of lung diseases and other NCDs like asthma, Pulmonary Fibrosis, and COPD.

Saudi Arabia Respiratory Care Devices Market

The respiratory care devices market in Saudi Arabia is propelled by significant government investments in the healthcare infrastructure along with the rising incidence of respiratory diseases in the country. The development of modern hospitals and medical cities has surged the demand for state-of-the-art equipment for respiratory patients. The Saudization of hospitals is currently under way in the region's hospitals; many hospitals have given hiring priority to Saudi citizens over foreign nationals. The growing concern for better critical care services in the country is facilitating the adoption of ventilators and monitors for respiratory patients in the Saudi Arabia respiratory care devices market. incarcerated Amongst the bunch of various exhibitors at the Arab Health exhibition in February 2025 was Respircare Company, featuring their recently launched products along with a full line of respiratory therapeutic products at the exhibition.

Market Segmentation

Device Type

  • Therapeutic Devices
  • Monitoring Devices
  • Diagnostic Devices
  • Consumables & Accessories

Products

  • Respiratory Consumables
  • Nebulizers
  • Oxygen Concentrators
  • Polysomnography Devices
  • Pulse Oximeter
  • Mechanical Ventilators
  • Spirometers
  • Others

Application

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Obstructive Sleep Apnea
  • Asthma
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Others

End Users

  • Hospitals
  • Home Care
  • Ambulatory Care

Countries

North America

  • United States
  • Canada

Europe

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherlands
  • Turkey

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • Malaysia
  • Indonesia
  • New Zealand

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • United Arab Emirates

All companies have been covered with 5 Viewpoints

  • Overview
  • Key Persons
  • Recent Development & Strategies
  • Product Portfolio
  • Financial Insights

Company Analysis

  • Medtronic Plc
  • Koninklijke Philips
  • General Electric Company
  • Masimo Corporation
  • ResMed Inc.
  • Becton Dickinson
  • Chart Industries Inc.
  • Getinge AB
  • InogenInc

Table of Contents

1. Introduction
2. Research & Methodology
2.1 Data Source
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Research Approach
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Forecast Projection Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Respiratory Care Devices Market
5.1 Historical Market
5.2 Market Forecast
6. Market Share Analysis
6.1 By Application
6.2 By Device Types
6.3 By Product Type
6.4 By End Users
6.5 By Countries
7. Application
7.1 Chronic Obstructive Pulmonary Disease (COPD)
7.1.1 Historical Market
7.1.2 Market Forecast
7.2 Obstructive Sleep Apnea
7.2.1 Historical Market
7.2.2 Market Forecast
7.3 Asthma
7.3.1 Historical Market
7.3.2 Market Forecast
7.4 Respiratory Distress Syndrome
7.4.1 Historical Market
7.4.2 Market Forecast
7.5 Cystic Fibrosis
7.5.1 Historical Market
7.5.2 Market Forecast
7.6 Others
7.6.1 Historical Market
7.6.2 Market Forecast
8. Device Type
8.1 Therapeutic Devices
8.1.1 Historical Market
8.1.2 Market Forecast
8.2 Monitoring Devices
8.2.1 Historical Market
8.2.2 Market Forecast
8.3 Diagnostic Devices
8.3.1 Historical Market
8.3.2 Market Forecast
8.4 Consumables & Accessories
8.4.1 Historical Market
8.4.2 Market Forecast
9. Product Type
9.1 Respiratory Consumables
9.1.1 Historical Market
9.1.2 Market Forecast
9.2 Nebulizers
9.2.1 Historical Market
9.2.2 Market Forecast
9.3 Oxygen Concentrators
9.3.1 Historical Market
9.3.2 Market Forecast
9.4 Polysomnography Devices
9.4.1 Historical Market
9.4.2 Market Forecast
9.5 Pulse Oximeter
9.5.1 Historical Market
9.5.2 Market Forecast
9.6 Mechanical Ventilators
9.6.1 Historical Market
9.6.2 Market Forecast
9.7 Spirometers
9.7.1 Historical Market
9.7.2 Market Forecast
9.8 Others
9.8.1 Historical Market
9.8.2 Market Forecast
10. End Users
10.1 Hospitals
10.1.1 Historical Market
10.1.2 Market Forecast
10.2 Home Care
10.2.1 Historical Market
10.2.2 Market Forecast
10.3 Ambulatory Care
10.3.1 Historical Market
10.3.2 Market Forecast
11. Countries
11.1 North America
11.1.1 United States
11.1.1.1 Historical Market
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Historical Market
11.1.2.2 Market Forecast
11.2 Europe
11.2.1 France
11.2.1.1 Historical Market
11.2.1.2 Market Forecast
11.2.2 Germany
11.2.2.1 Historical Market
11.2.2.2 Market Forecast
11.2.3 Italy
11.2.3.1 Historical Market
11.2.3.2 Market Forecast
11.2.4 Spain
11.2.4.1 Historical Market
11.2.4.2 Market Forecast
11.2.5 United Kingdom
11.2.5.1 Historical Market
11.2.5.2 Market Forecast
11.2.6 Belgium
11.2.6.1 Historical Market
11.2.6.2 Market Forecast
11.2.7 Netherlands
11.2.7.1 Historical Market
11.2.7.2 Market Forecast
11.2.8 Turkey
11.2.8.1 Historical Market
11.2.8.2 Market Forecast
11.3 Asia Pacific
11.3.1 China
11.3.1.1 Historical Market
11.3.1.2 Market Forecast
11.3.2 Japan
11.3.2.1 Historical Market
11.3.2.2 Market Forecast
11.3.3 India
11.3.3.1 Historical Market
11.3.3.2 Market Forecast
11.3.4 Australia
11.3.4.1 Historical Market
11.3.4.2 Market Forecast
11.3.5 South Korea
11.3.5.1 Historical Market
11.3.5.2 Market Forecast
11.3.6 Thailand
11.3.6.1 Historical Market
11.3.6.2 Market Forecast
11.3.7 Malaysia
11.3.7.1 Historical Market
11.3.7.2 Market Forecast
11.3.8 Indonesia
11.3.8.1 Historical Market
11.3.8.2 Market Forecast
11.3.9 New Zealand
11.3.9.1 Historical Market
11.3.9.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Historical Market
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Historical Market
11.4.2.2 Market Forecast
11.4.3 Argentina
11.4.3.1 Historical Market
11.4.3.2 Market Forecast
11.5 Middle East & Africa
11.5.1 South Africa
11.5.1.1 Historical Market
11.5.1.2 Market Forecast
11.5.2 Saudi Arabia
11.5.2.1 Historical Market
11.5.2.2 Market Forecast
11.5.3 UAE
11.5.3.1 Historical Market
11.5.3.2 Market Forecast
12. Porter's Five Forces Analysis
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Competition
12.4 Threat of New Entrants
12.5 Threat of Substitutes
13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threats
14. Key Players Analysis
14.1 Medtronic Plc.
14.1.1 Overviews
14.1.2 Key Person
14.1.3 Recent Developments
14.1.4 SWOT Analysis
14.1.5 Revenue Analysis
14.2 Koninklijke Philips
14.2.1 Overviews
14.2.2 Key Person
14.2.3 Recent Developments
14.2.4 SWOT Analysis
14.2.5 Revenue Analysis
14.3 General Electric Company
14.3.1 Overviews
14.3.2 Key Person
14.3.3 Recent Developments
14.3.4 SWOT Analysis
14.3.5 Revenue Analysis
14.4 Masimo Corporation
14.4.1 Overviews
14.4.2 Key Person
14.4.3 Recent Developments
14.4.4 SWOT Analysis
14.4.5 Revenue Analysis
14.5 ResMedInc
14.5.1 Overviews
14.5.2 Key Person
14.5.3 Recent Developments
14.5.4 SWOT Analysis
14.5.5 Revenue Analysis
14.6 Becton Dickinson
14.6.1 Overviews
14.6.2 Key Person
14.6.3 Recent Developments
14.6.4 SWOT Analysis
14.6.5 Revenue Analysis
14.7 Chart Industries Inc.
14.7.1 Overviews
14.7.2 Key Person
14.7.3 Recent Developments
14.7.4 SWOT Analysis
14.7.5 Revenue Analysis
14.8 Getinge AB
14.8.1 Overviews
14.8.2 Key Person
14.8.3 Recent Developments
14.8.4 SWOT Analysis
14.8.5 Revenue Analysis
14.9 Inogen Inc.
14.9.1 Overviews
14.9.2 Key Person
14.9.3 Recent Developments
14.9.4 SWOT Analysis
14.9.5 Revenue Analysis

Companies Mentioned

The companies featured in this Respiratory Care Devices market report include:
  • Medtronic Plc
  • Koninklijke Philips
  • General Electric Company
  • Masimo Corporation
  • ResMed Inc.
  • Becton Dickinson
  • Chart Industries Inc.
  • Getinge AB
  • InogenInc

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information